AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2005
Aug 23, 2005
34519_dirs_2005-08-23_14f7ce92-39db-4932-b33b-c75fd94fd805.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2005-08-22
Reporting Person: Rhodes Linda (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.10 par value | 15000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified stock option (Right to Buy) | $4.67 | 2010-08-22 | Common Stock (15000) | Direct |
Footnotes
F1: This option vests according to the following schedule, provided that Optionee is re-elected as a director at each such meeting:
(i) 5,000 shares on and after the 2006 Annual Meeting of Shareholders;
(ii) an additional 5,000 shares on and after the 2007 Annual Meeting of Shareholders; and
(iii) the remaining 5,000 shares on and after the 2008 Annual Meeting of Shareholders.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23